Stay updated with breaking news from Genentech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place?
After the pandemic shined a spotlight on public health, it remains an in-demand field.
/PRNewswire/ -- Lupus advocates from across the nation converged on Capitol Hill for the National Lupus Advocacy Summit May 19-21. Hosted by the Lupus...
SAN DIEGO — Few patients are evaluated based on all seven endpoints of guidelines indicating complete asthma remission, according to a poster presented at the American Thoracic Society International Meeting. Standardized protocols that include all these domains are needed for accurate assessment of asthma remission, Thomas C. Corbridge, MD, FCCP, U.S. senior medical lead, respiratory
The FDA approved the first 2 biosimilars referencing aflibercept (Eylea). (aflibercept). However, patent litigation has left it unclear when the biosimilars will come to market.